Mistaken Identities

Researchers are working to automate the arduous task of identifying—and amending—mislabeled sequences in genetic databases.

Written byKerry Grens
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

FLICKR, KEVIN MACKENZIE, UNIVERSITY OF ABERDEENResearchers at King’s College London were working on some human gene expression experiments in 2008 when they got a strong match to one of the probe sequences in an Affymetrix microarray. The only available information on the gene from the chip was that it was a human sequence, recalled William Langdon, who helped on the project. So the team did a BLAST search to look up more information. “And the first thing you get back is, of course, the human sequence itself,” said Langdon, who is now at University College London. But when he scanned down the list of the other related sequences that appeared in the search, it was apparent something was amiss. “They [were] all different species of Mycoplasma.”

It appeared a case of mistaken identity; the original submitter of the sequence to GenBank must have had Mycoplasma contamination in a human sample, and assumed the sequence was human. In a study Langdon and colleagues published in 2009, the authors show the striking resembling between this “human” sequence and a particular marker sequence from various Mycoplasma species.

To this day, the sequence is still labeled “Homo sapiens unknown” in the National Center for Biotechnology Information (NCBI) database Genbank. This misnomer represents one of the hundreds—perhaps thousands—of sequences deposited to GenBank and elsewhere that have been assigned to the wrong taxon.

That errors exist in GenBank and other databases is a truism. But correcting mislabeled sequences is a difficult task, one that database stewards and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform